Random Medicaid Assignment Finds Lower Costs Under Managed Care

Key Takeaways

• Private managed care was associated with 5.6% lower costs than public fee-for-service in the randomized Medicaid comparison.
• Reported savings were linked to prescription-drug substitution and lower outpatient prices.
• Pharmacy utilization management was identified as a key mechanism, with no decrease in observed quality reported, while privatized medical benefits showed only modest savings and decreased health care quality and consumer satisfaction.

In a randomized comparison of nearly 100,000 Medicaid enrollees, private managed care reduced costs by 5.6% versus a publicly operated fee-for-service system in an American Economic Review randomized Medicaid analysis. The study compared two ways of administering Medicaid coverage within the same randomized framework rather than through an observational contrast. That spending difference was observed under random assignment between the two systems, framing it as a comparison between administrative models rather than enrollee selection patterns.

The study was a primary randomized Medicaid analysis published in American Economic Review, examining privatization of social health insurance. Researchers used a private managed care and public fee-for-service Medicaid comparison created through random assignment, with enrollees entering one administrative model or the other. The analysis distinguishes between pharmacy benefits and medical benefits, and that split shapes the reported cost, quality, and satisfaction findings.

Reported savings were attributed to cost-effective substitutions among prescription drugs and lower prices for outpatient services, pointing to two channels rather than one. The authors also identified pharmacy utilization management as the key mechanism, linking lower spending to reduced overuse and substitution toward lower-cost drugs. Within that pharmacy-focused result, no decrease in observed quality was reported. The mechanism remained centered on drug management and outpatient pricing.

The findings for medical benefits were less favorable than the pharmacy-side results. Privatizing medical benefits produced only modest savings and was associated with decreased health care quality and consumer satisfaction. In this randomized Medicaid comparison, the clearest split was between pharmacy-related savings without an observed quality decrease and weaker medical-benefit results with lower quality and satisfaction.